2.1 Practice Management, Billing, Coding & Documentation

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

2.1 Practice Management, Billing, Coding & Documentation

Key Takeaways Explain This Topic AI

Under the revised AMA/CMS Evaluation and Management (E/M) guidelines, outpatient visit levels (99202–99215) are determined exclusively by Medical Decision Making (MDM) or total clinician time on the encounter date; history and physical exam are recorded as medically appropriate but no longer numerically scored.

Medical Decision Making requires meeting or exceeding threshold criteria in at least two of three domains: 1) Number and complexity of problems addressed, 2) Amount and/or complexity of data reviewed and analyzed, and 3) Risk of complications, morbidity, or mortality of patient management.

Prescription drug management (initiating, discontinuing, or titrating a prescription medication) automatically qualifies as Moderate Risk under MDM, whereas drug therapy requiring intensive monitoring for toxicity (e.g., warfarin with INR, lithium with serum drug levels) qualifies as High Risk.

Medicare 'incident-to' billing permits advanced practice clinicians (NPs, PAs) to be reimbursed at 100% of the physician fee schedule, but strictly requires the physician to establish the care plan, maintain direct on-site supervision, and is prohibited when evaluating new medical problems.

Hierarchical Condition Categories (HCC) risk adjustment scores reset to zero annually on January 1; clinicians must re-document and code all chronic conditions every calendar year using MEAT (Monitor, Evaluate, Assess, Treat) criteria to maintain accurate patient risk profiles.

Last updated: September 2026

Modern Evaluation and Management (E/M) Guidelines

For nearly three decades, Evaluation and Management (E/M) documentation was governed by the 1995 and 1997 CMS documentation guidelines. Those legacy frameworks required clinicians to perform and document rigid, formulaic counts of organ systems in the Review of Systems (ROS) and physical examination to justify billing levels. This created massive administrative overhead, contributed significantly to physician burnout, and incentivized meaningless electronic health record (EHR) text generation ("note bloat").

In 2021, the American Medical Association (AMA) and the Centers for Medicare & Medicaid Services (CMS) completely overhauled outpatient office visit E/M coding (CPT codes 99202–99215), subsequently extending these principles to inpatient, observation, and consultation codes in 2023. Under modern guidelines:

Elimination of History and Physical Exam Scoring : History and physical examination elements are no longer scored or counted to determine the code level. While clinicians must still document a medically appropriate history and examination to guide clinical care, these elements have zero mathematical impact on code level selection.

Code Level Determination Modalities : Outpatient office visit codes are determined exclusively by either:

Medical Decision Making (MDM) ; OR

Total Clinician Time spent on the date of the encounter.

Retirement of CPT 99201 : CPT code 99201 (Level 1 new patient) was permanently deleted because new patient encounters inherently require at least straightforward medical decision making.

CPT 99211 Remains Available : CPT 99211 (Level 1 established patient) does not require physician presence or medical decision making; it is utilized for clinical staff visits (e.g., nurse blood pressure check, routine tuberculin skin test read, vaccine administration without physician consultation).

Medical Decision Making (MDM) Deep Dive: The Three Components

Medical Decision Making reflects the cognitive complexity of establishing diagnoses, evaluating diagnostic data, and selecting therapeutic interventions. To establish an MDM level for an encounter, at least two of the three MDM elements must meet or exceed the requirements for that level:

Number and Complexity of Problems Addressed at the Encounter
Amount and/or Complexity of Data to Be Reviewed and Analyzed
Risk of Complications and/or Morbidity or Mortality of Patient Management
Master MDM Classification Matrix

MDM Level CPT New Patient CPT Established Patient Number & Complexity of Problems Amount/Complexity of Data Risk of Patient Management

Straightforward (Level 2) 99202 99212 1 self-limited or minor problem Minimal or none Minimal risk of morbidity from additional diagnostic testing or treatment

Low Complexity (Level 3) 99203 99213 2+ self-limited or minor problems; OR 1 stable chronic illness; OR 1 acute uncomplicated illness/injury Limited data (must meet at least 1 of 2 categories) Low risk of morbidity from additional diagnostic testing or treatment (e.g., OTC medications, physical therapy)

Moderate Complexity (Level 4) 99204 99214 1+ chronic illness with mild exacerbation/progression; OR 2+ stable chronic illnesses; OR 1 undifferentiated new problem with uncertain prognosis; OR 1 acute illness with systemic symptoms; OR 1 acute complicated injury Moderate data (must meet at least 1 of 3 categories) Moderate risk of morbidity from treatment (e.g., prescription drug management , minor surgery with risk, diagnosis/treatment limited by SDOH)

High Complexity (Level 5) 99205 99215 1+ chronic illness with severe exacerbation/progression; OR 1 acute or chronic illness/injury posing a threat to life or bodily function Extensive data (must meet at least 2 of 3 categories) High risk of morbidity from treatment (e.g., drug therapy requiring intensive monitoring for toxicity , emergency surgery, hospitalization decision)

Detailed Analysis of MDM Element 1: Number & Complexity of Problems Addressed

Self-Limited or Minor Problem : A problem that runs a definite, prescribed course, is transient in nature, and is not likely to permanently alter health status (e.g., viral upper respiratory infection, localized contact dermatitis, uncomplicated cerumen impaction).

Stable Chronic Illness : A chronic illness with a specific expected duration of at least one year or until the death of the patient, whose treatment goal is currently being met without progression or severe side effects (e.g., well-controlled hypertension on lisinopril, stable type 2 diabetes with HbA1c 6.8%). Addressing two stable chronic illnesses qualifies for Moderate Complexity.

Chronic Illness with Exacerbation, Progression, or Side Effects of Treatment : A chronic problem that is worsening, poorly controlled, or progressing despite therapy, or experiencing adverse effects of current therapy (e.g., diabetic patient with microalbuminuria and elevated blood pressure requiring medication adjustment; rheumatoid arthritis with active joint flare). Qualifies for Moderate Complexity.

Undifferentiated Illness with Uncertain Prognosis : A new presentation with diagnostic ambiguity that carries the potential for high morbidity if untreated (e.g., a new breast lump, unexplained involuntary weight loss with fatigue, acute undifferentiated abdominal pain). Qualifies for Moderate Complexity.

Acute Illness with Systemic Symptoms : An acute condition involving constitutional symptoms such as fever, tachycardia, or profound malaise (e.g., acute pyelonephritis, pneumonia, acute influenza with dehydration). Qualifies for Moderate Complexity.

Chronic Illness with Severe Exacerbation, Progression, or Treatment Side Effects : Severe decompensation of a chronic condition that carries significant risk of morbidity and often mandates escalation of care (e.g., severe acute decompensated heart failure with resting orthopnea, severe COPD exacerbation with resting hypoxia). Qualifies for High Complexity.

Acute or Chronic Illness/Injury Posing a Threat to Life or Bodily Function : Critical, life-threatening conditions (e.g., acute myocardial infarction, acute pulmonary embolism, acute stroke, suicidal ideation with plan, unstable gastrointestinal hemorrhage). Qualifies for High Complexity.

Detailed Analysis of MDM Element 2: Amount & Complexity of Data Reviewed

To achieve Limited Data (Level 3), the clinician must meet Category 1 (any combination of 2: review of external records from unique source, review of unique test results, ordering unique tests) OR Category 2 (assessment requiring an independent historian, such as a parent or caregiver for a demented adult).

To achieve Moderate Data (Level 4), the encounter must fulfill at least one of the following three categories :

Category 1 (Tests, documents, or independent historian) : Any combination of 3 of the following:

Review of prior external notes from each unique source
Review of the result of each unique diagnostic test
Ordering of each unique diagnostic test
Assessment requiring an independent historian

Category 2 (Independent interpretation of tests) : Independent interpretation of a diagnostic test performed by another physician/qualified healthcare professional (QHP) that is not separately reported (e.g., personally reviewing and interpreting an outpatient 12-lead ECG, spirometry tracing, or plain radiograph).

Category 3 (Discussion of management or test interpretation) : Direct discussion of management or test results with an external physician or other qualified healthcare professional (e.g., calling a consulting cardiologist, infectious disease specialist, or reading radiologist).

To achieve Extensive Data (Level 5), the encounter must fulfill at least two of the three categories outlined under Moderate Data.

Detailed Analysis of MDM Element 3: Risk of Complications, Morbidity, or Mortality

Risk is defined as the clinician's assessment of patient management decisions taken during the visit:

Low Risk : Over-the-counter (OTC) medications (e.g., recommending acetaminophen or topical hydrocortisone), physical therapy, minor surgery without identified patient or procedural risk.

Moderate Risk :

Prescription Drug Management : Initiating a new prescription medication, discontinuing a medication, titrating dosages, or reviewing medications with an explicit decision to maintain current dosages based on active clinical evaluation.

Decision Regarding Minor Surgery with Identified Risk Factors : E.g., performing a skin excision on an anticoagulated patient.

Decision Regarding Elective Major Surgery Without Identified Patient Risk Factors .

Diagnosis or Treatment Significantly Limited by Social Determinants of Health (SDOH) : E.g., economic hardship preventing prescription fulfillment, housing instability limiting insulin refrigeration.

High Risk :

Drug Therapy Requiring Intensive Monitoring for Toxicity : Monitoring must be designed to assess for potential serious or life-threatening adverse effects, rather than routine therapeutic efficacy. The drug must have a narrow therapeutic index or significant organ toxicity requiring repeated laboratory monitoring. Classic board examples: Warfarin (requiring serial INR monitoring), Lithium (requiring serial serum drug levels and renal/thyroid monitoring), Methotrexate or Systemic Immunosuppressants (requiring frequent CBC, hepatic, and renal surveillance), and Amiodarone (requiring periodic hepatic, thyroid, and pulmonary toxicity monitoring). Exam Pearl : Routine lipid panels for statins or periodic basic metabolic panels for stable ACE inhibitor or ARB therapy do NOT qualify as intensive toxicity monitoring.

Decision Regarding Elective Major Surgery with Identified Patient Risk Factors .

Decision Regarding Emergency Major Surgery .

Decision Regarding Hospitalization or Escalation of Care : Deciding to admit a patient to an acute care inpatient ward, observation unit, or emergency department.

Decision Not to Resuscitate or De-escalate Care Due to Poor Prognosis : Formally establishing comfort measures or DNR/DNI orders.

Time-Based E/M Coding Rules

When billing E/M visits based on time, clinicians record the total clinician time spent on the date of the encounter (both face-to-face and non-face-to-face time). Time spent by clinical staff (medical assistants, nurses) cannot be counted toward physician time.

Outpatient Encounter Time Thresholds

CPT Code Patient Status Required Total Clinician Time on Date of Encounter
99202 New Patient 15–29 minutes
99203 New Patient 30–44 minutes
99204 New Patient 45–59 minutes
99205 New Patient 60–74 minutes

+99417 New or Established Each additional 15 minutes beyond primary threshold (beyond 74 min for 99205; beyond 54 min for 99215)

99211 Established Patient N/A (Clinical staff visit; no clinician time requirement)
99212 Established Patient 10–19 minutes
99213 Established Patient 20–29 minutes
99214 Established Patient 30–39 minutes
99215 Established Patient 40–54 minutes
Qualifying Activities That Count Toward Total Clinician Time

Total time includes all professional work performed by the reporting clinician on the calendar date of the encounter:

Reviewing the patient's medical record, diagnostic tests, and external hospital or specialist records prior to the encounter

Obtaining and reviewing a patient history and performing a physical examination
Counseling and educating the patient, family, or caregiver
Ordering medications, diagnostic studies, therapies, or subspecialty consultations
Documenting clinical notes and progress reports in the electronic health record
Independent interpretation of diagnostic tests that are not separately billed
Communicating with other healthcare professionals regarding the patient's clinical care
Care coordination activities performed on the date of the encounter

Excluded Activities : Time spent performing separately billable clinical procedures (e.g., cryotherapy, arthrocentesis, laceration repair, ECG interpretation billed under 93000) cannot be double-counted toward E/M encounter time. Travel time and general administrative teaching time are also excluded.

CPT Modifiers in Primary Care: Modifier 25 & Modifier 59

Modifiers provide additional contextual information to third-party payers regarding clinical services rendered:

Modifier 25: Significant, Separately Identifiable E/M Service

Definition : Appended to an E/M CPT code (e.g., 99213, 99214) to indicate that on the same day as a minor procedure or preventive medicine examination, the patient's condition required a significant, separately identifiable evaluation and management service above and beyond the usual pre- and post-procedure care.

Clinical Application 1 (Preventive Visit + Acute/Chronic Problem) : An established adult presents for an annual preventive physical exam (CPT 99396). During the encounter, the patient reports 3 weeks of progressive knee pain with joint effusion. The clinician performs a separate musculoskeletal evaluation, establishes a diagnosis of knee osteoarthritis, orders plain radiographs, and prescribes an oral NSAID. Billing: 99396 (Preventive Visit) AND 99213-25 or 99214-25 (Separately Identifiable Problem E/M).

Clinical Application 2 (E/M Visit + In-Office Minor Procedure) : A patient presents with acute shoulder pain. The clinician evaluates the shoulder (Moderate MDM), establishes a diagnosis of subacromial bursitis, discusses risks/benefits of corticosteroid injection, and immediately performs a subacromial bursa injection (CPT 20610). Billing: 99214-25 (Significant E/M Service) AND 20610 (Arthrocentesis/Injection of Major Joint).

Audit Vulnerability : Documentation must clearly distinguish the separate problem-oriented history, exam, and medical decision making from the procedure itself. Modifier 25 should never be appended automatically or without documentation supporting a separate service.

Modifier 59: Distinct Procedural Service

Definition : Identifies that a non-E/M procedure or service was distinct or independent from other non-E/M services performed on the same day (e.g., excising a benign lesion from the arm and performing an unrelated biopsy of a suspicious pigmented lesion on the back during the same encounter).

Relative Value Units (RVUs) and Reimbursement Mechanics

Medicare and commercial payers calculate physician reimbursement using the Resource-Based Relative Value Scale (RBRVS) . Rather than paying arbitrary charges, each CPT code is assigned a standardized Relative Value Unit (RVU) weight that reflects the resource intensity required to deliver that service.

The Medicare Physician Fee Schedule Formula Payment = [ ( wRVU × Work GPCI ) + ( peRVU × PE GPCI ) + ( mpRVU × MP GPCI ) ] × Conversion Factor (CF) \text{Payment} = [(\text{wRVU} \times \text{Work GPCI}) + (\text{peRVU} \times \text{PE GPCI}) + (\text{mpRVU} \times \text{MP GPCI})] \times \text{Conversion Factor (CF)} Payment = [( wRVU × Work GPCI ) + ( peRVU × PE GPCI ) + ( mpRVU × MP GPCI )] × Conversion Factor (CF)

The Three Components of an RVU

Work RVU (wRVU) (~50% to 55% of Total Value) : Reflects the clinician's cognitive time, technical procedural skill, physical effort, clinical judgment, and mental stress required to deliver the service. In most health system employment contracts, wRVU productivity serves as the primary metric for physician compensation and productivity bonuses.

Practice Expense RVU (peRVU) (~40% to 45% of Total Value) : Reflects the non-physician overhead costs of operating a medical clinic, including clinical support staff salaries (nurses, medical assistants), commercial building rent, administrative utilities, medical equipment depreciation, and surgical/office supplies.

Malpractice / Professional Liability Insurance RVU (mpRVU) (~3% to 5% of Total Value) : Reflects the specialty-specific cost of purchasing medical professional liability insurance premiums.

Geographic Adjustments & The Conversion Factor

Geographic Practice Cost Indices (GPCI) : CMS applies three distinct GPCIs (Work GPCI, Practice Expense GPCI, and Malpractice GPCI) to adjust payments based on regional variations in physician labor markets, office rents, and state liability climates.

Conversion Factor (CF) : A national dollar multiplier established annually by CMS through federal rulemaking (e.g., approximately $32 to $34 per RVU in recent cycles). Multiplying the geographically adjusted total RVU by the national conversion factor yields the exact allowable Medicare payment amount.

Value-Based Care, MACRA, and MIPS

United States healthcare financing is undergoing a profound paradigm shift from traditional volume-driven Fee-for-Service (FFS) models to value-driven Value-Based Care (VBC) models:

Fee-for-Service Limitations : Incentivizes high procedure volume, fragmented specialty care, and short face-to-face visits, while failing to reimburse chronic disease coordination, care management, and disease prevention.

Value-Based Care Goals : Incentivizes healthcare systems and primary care physicians to achieve high-quality clinical outcomes, optimize population health, enhance patient experience, and reduce total cost of care (the "Quadruple Aim").

MACRA: The Medicare Access and CHIP Reauthorization Act

Enacted in 2015, MACRA permanently repealed the widely criticized Sustainable Growth Rate (SGR) formula and established the Quality Payment Program (QPP) , creating two distinct reimbursement tracks for Medicare Part B providers: ┌─────────────────────────────────────┐

│ Quality Payment Program │
│ (QPP) │
└──────────────────┬──────────────────┘
│
┌───────────────────────┴───────────────────────┐
▼ ▼
┌─────────────────────────┐ ┌─────────────────────────┐
│ MIPS │ │ Advanced APMs │
│ (Merit-based Incentive │ │ (Alternative Payment │
│ Payment System) │ │ Models) │
└────────────┬────────────┘ └────────────┬────────────┘
│ │

4 Weighted Categories: Qualifying Participants:

Quality (30%) • MSSP ACO (Risk Tracks)
Cost (30%) • Primary Care First
Promoting Interoperability (25%) • CPC+ / ACO REACH
Improvement Activities (15%) • Exempt from MIPS
➔ +/- 9% Medicare Adjustment ➔ Lump-sum 3.5-5% Bonus
Merit-Based Incentive Payment System (MIPS)

MIPS consolidates legacy quality programs (PQRS, Meaningful Use, Value-Based Modifier) into a single composite performance score (0 to 100 points) divided across four weighted performance categories:

Quality (30% Weight) : Clinicians report performance on evidence-based quality measures (e.g., blood pressure control <140/90 mm Hg, diabetic HbA1c control <8.0%, colorectal cancer screening rates, tobacco cessation interventions).

Cost (30% Weight) : Calculated by CMS using administrative claims data without requiring direct provider reporting (e.g., total per-capita healthcare costs, Medicare Spending per Beneficiary).

Promoting Interoperability (25% Weight) : Focuses on EHR utilization, patient portal access, electronic prescribing, and secure bidirectional exchange of clinical health data.

Improvement Activities (15% Weight) : Practice-level operational enhancements (e.g., implementing expanded clinical hours, establishing same-day appointments, participating in clinical registries, integrating behavioral health).

Financial Penalties and Bonuses : Based on the composite score relative to a national performance threshold, clinicians receive a positive, neutral, or negative payment adjustment (up to +/- 9%) applied to all Medicare Part B claims two years post-performance.

Advanced Alternative Payment Models (Advanced APMs)

Clinicians who achieve "Qualifying Participant" (QP) status by delivering a substantial threshold of patient care or revenue through risk-bearing Advanced APMs (such as Medicare Shared Savings Program ACO Level E, Primary Care First, or ACO REACH) are completely exempt from MIPS reporting and receive an annual lump-sum incentive bonus.

Hierarchical Condition Categories (HCC) & Risk Adjustment

In value-based contracts (such as Medicare Advantage and Accountable Care Organizations), healthcare payers utilize the CMS Hierarchical Condition Category (CMS-HCC) model to predict prospective healthcare expenditures and adjust capitated payments based on the disease burden of enrolled patient panels.

Risk Adjustment Factor (RAF) Score Architecture

Each patient is assigned an individualized Risk Adjustment Factor (RAF) score . A baseline healthy Medicare beneficiary has a RAF score of 1.0.

A higher RAF score indicates higher expected disease complexity, healthcare utilization, and cost. Payers allocate significantly higher monthly capitation payments to practices managing higher-RAF patients to support intensive care management.

RAF scores are calculated by combining demographic factors (age, sex, Medicaid dual-eligibility, institutional status) with disease-specific HCC clinical coefficients derived directly from submitted ICD-10 diagnostic codes.

The Critical Annual Reset Rule

HCC Codes Drop Off Annually : Under CMS rules, all HCC diagnostic categories reset to zero on January 1 of each calendar year . Diagnostic codes submitted in year 1 do not automatically carry over into year 2.

Annual Documentation Mandate : Clinicians must document and bill every active chronic condition at least once per calendar year during a face-to-face encounter.

Consequences of Omission : If a patient with chronic heart failure (HFrEF) and stage 4 CKD is seen multiple times in a year but the physician codes only "routine follow-up" or acute sinusitis, those HCCs expire. The patient's RAF score drops toward 1.0, making them appear misleadingly "healthy" on paper. This severely underfunds the practice's care coordination resources and artificially distorts quality metrics.

The MEAT Documentation Standard

To withstand rigorous CMS Risk Adjustment Data Validation (RADV) audits, every reported HCC diagnosis must be supported in the clinical encounter note by documenting at least one element of MEAT :

M — Monitor : Documenting signs, symptoms, disease progression, disease regression, or stability (e.g., "No lower extremity edema, orthopnea, or dyspnea on exertion").

E — Evaluate : Reviewing diagnostic test results, lab panels, medication effectiveness, or response to therapy (e.g., "HbA1c remains stable at 7.1% on current regimen").

A — Assess : Providing clinical analysis, discussion, or diagnostic status (e.g., "Chronic kidney disease stage 3b, stable without acute decline").

T — Treat : Documenting therapeutic action, initiating/continuing medications, ordering diagnostic tests, or consulting specialists (e.g., "Continue lisinopril 20 mg daily, recheck renal panel and urine albumin-to-creatinine ratio in 6 months").

Incident-To Billing Rules for Advanced Practice Clinicians

In ambulatory primary care clinics, Advanced Practice Clinicians—Nurse Practitioners (NPs) and Physician Assistants (PAs)—play an essential clinical role. Medicare establishes two pathways for billing APC services in the outpatient office setting:

Direct APC Billing : The service is billed under the NP or PA's own National Provider Identifier (NPI). Reimbursement is set by statute at 85% of the Medicare Physician Fee Schedule .

Incident-To Billing : The service is billed under the supervising physician's NPI, reimbursing at 100% of the Medicare Physician Fee Schedule .

Strict Statutory Criteria for Incident-To Billing

To bill a service "incident-to" a physician, all four of the following criteria must be met :

Initial Service by Physician : The physician must have personally performed the initial evaluation, established the diagnosis, and formulated the initial comprehensive plan of care for that specific medical condition.

Direct Personal Supervision : The supervising physician must be physically present in the office suite and immediately available to render assistance and direction. The physician does not need to enter the exam room, but telephonic, virtual, or off-site coverage strictly violates incident-to requirements.

Ongoing Physician Involvement : The physician must maintain active, periodic participation in the management of the established condition.

NO NEW MEDICAL PROBLEMS : If an established patient presents with a new medical problem , or if an established condition acutely destabilizes requiring a fundamental change in the treatment plan that the physician does not personally evaluate, the encounter CANNOT be billed incident-to . The entire visit must be billed directly under the NP or PA's own NPI at the 85% rate.

Employment Requirement : The APC and the supervising physician must be employed by or contracted with the same legal medical entity.

Split/Shared Billing Clarification : Split/shared billing (where a physician and APC both perform substantive portions of an encounter) applies exclusively to facility-based settings (inpatient hospital, hospital outpatient clinic, observation unit, or emergency department). Split/shared billing is not permitted in private ambulatory office settings, where incident-to rules govern.

Healthcare Compliance, Documentation Integrity & Federal Statutes

Family physicians must understand federal healthcare compliance laws to prevent severe civil liability and criminal penalties:

Key Federal Healthcare Fraud and Abuse Statutes

False Claims Act (FCA) : Prohibits knowingly presenting, or causing to be presented, a false or fraudulent claim for payment to federal healthcare programs (Medicare/Medicaid). "Knowingly" includes not only deliberate fraud, but also deliberate ignorance or reckless disregard of coding accuracy. Carries substantial civil monetary penalties (over $13,000 to $27,000 per false claim) plus treble damages (triple the amount of the false claim). Contains qui tam (whistleblower) provisions allowing private individuals to file lawsuits on behalf of the government.

Anti-Kickback Statute (AKS) : A criminal statute prohibiting the knowing and willful solicitation, receipt, offer, or payment of any remuneration (cash, gifts, expensive trips, consulting fees) to induce or reward patient referrals or generate business for items or services reimbursed by federal healthcare programs. Violations constitute a felony punishable by up to 10 years imprisonment, criminal fines, and mandatory exclusion from Medicare/Medicaid.

Stark Law (Physician Self-Referral Law) : A strict liability civil statute that prohibits a physician from referring Medicare or Medicaid patients for Designated Health Services (DHS) —including clinical laboratory services, physical therapy, radiology/imaging, home health, and outpatient prescription drugs—to an entity with which the physician (or an immediate family member) has a financial relationship (ownership, investment, or compensation), unless an explicit statutory exception (e.g., In-Office Ancillary Services Exception) is fully satisfied. Because it is strict liability, intent to defraud does not need to be proven.

EHR Documentation Integrity: The Dangers of "Copy-and-Paste"

Modern EHR systems feature convenient tools—such as "copy forward," pre-templated "dot phrases," and automated physical exam population. When misused, these features generate severe compliance vulnerabilities:

"Note Bloat" & Cloned Records : Copying physical exam findings from a visit 6 months prior can result in documenting an intact right leg on a patient who recently underwent an above-knee amputation, or charting clear lung fields during an active pneumonia visit.

Medical Audit Vulnerability : In federal compliance audits, cloned physical exams or contradictory documentation (e.g., review of systems documenting "no abdominal pain" while the HPI notes "severe epigastric cramping") are deemed non-credible, leading to complete claims denials and allegations of fraudulent billing.